Johnson & Johnson COVID-19 vaccine production blunder doesn’t impact distributed doses, White House says
Fox News
The production error that occurred at Emergent BioSolutions and saw millions of the Johnson & Johnson COVID-19 vaccine discarded does not impact already distributed doses, the White House said on Friday.
Workers at the Baltimore production facility reportedly mixed ingredients from the Johnson & Johnson vaccine with those from the yet-to-be-approved AstraZeneca jab. On Thursday, the Associated Press revealed that Emergent BioSolutions has a history of citations from the FDA for issues regarding poorly trained employees, cracked vials and mold at one of its facilities. Johnson & Johnson delivered 20 million doses by the end of March, and has committed to deliver an additional 24 million in the month of April.More Related News